Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer

Affiliations

• ¹ Department of Hepatobiliary Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang 322100, PR China.
• ² Department of Translational Medicine Center, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China; Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China.
• ³ Department of Translational Medicine Center, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China; Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China. Electronic address: 20171129@hznu.edu.cn.